Hodgkin lymphoma (HL) is an uncommon malignancy of B-cell origin. Classical HL (cHL)
and nodular lymphocyte–predominant HL are the 2 main types of HL. The cure rates for HL …

Purpose As brachytherapy utilization rates decline, we sought to evaluate the state of
brachytherapy training during radiation oncology residency. Methods and Materials US radiation …

PURPOSE External-beam radiation therapy (RT) is standard of care (SOC) for pain relief of
symptomatic bone metastases. We aimed to evaluate the efficacy of radiation to …

Introduction There are limited randomized data comparing radical cystectomy (RC) with
bladder-sparing tri-modality therapy (TMT) in the treatment of muscle-invasive bladder cancer (…

Radiotherapy plays an important role in managing highly radiosensitive, indolent non-Hodgkin
lymphomas, such as follicular lymphoma and marginal zone lymphoma. Although the …

PURPOSE: To examine patterns of failure in patients with parameningeal rhabdomyosarcoma
(PM-RMS) treated with intensity modulated radiation therapy (IMRT). METHODS AND …

When the pivotal phase 2 ZUMA-1 trial was first published in the New England Journal of
Medicine in 2017, chimeric antigen receptor (CAR) T-cell therapy was widely regarded as a …

Background In patients with metastatic cancer, the bone is the third-most common site of
involvement. Radiation to painful bone metastases results in high rates of pain control and is an …

Childhood cancer survivors are at risk for developing second malignant neoplasms. Very-low-dose
therapeutic radiation therapy (RT) may be used to treat infants with Stage 4S …

Background Castleman disease (CD) is a rare polyclonal lymphoproliferative disorder of
unclear etiology. Standard therapy for unicentric CD is surgical resection. Radiotherapy can be …